Russell Peloquin - SQI Diagnostics VP Operations

SQIDFDelisted Stock  USD 0.01  0.00  0.00%   

Insider

Russell Peloquin is VP Operations of SQI Diagnostics
Phone416 674 9500
Webhttps://www.sqidiagnostics.com

SQI Diagnostics Management Efficiency

The company has return on total asset (ROA) of (0.9421) % which means that it has lost $0.9421 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (12.5407) %, meaning that it generated substantial loss on money invested by shareholders. SQI Diagnostics' management efficiency ratios could be used to measure how well SQI Diagnostics manages its routine affairs as well as how well it operates its assets and liabilities.
SQI Diagnostics has accumulated 6.3 M in total debt with debt to equity ratio (D/E) of 4.64, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. SQI Diagnostics has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist SQI Diagnostics until it has trouble settling it off, either with new capital or with free cash flow. So, SQI Diagnostics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like SQI Diagnostics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for SQI to invest in growth at high rates of return. When we think about SQI Diagnostics' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Richard ColemanStar Equity Holdings
68
Rebecca FischerEnzo Biochem
52
Mark MBAVolitionrx
53
Simon MorrissGenetic Technologies
51
Dov OppenheimDarioHealth Corp
N/A
Alex ArzenoIntelligent Bio Solutions
N/A
Aaron SatoTwist Bioscience Corp
N/A
Bobbi CoffinBiodesix
N/A
Sri KalluriEXACT Sciences
N/A
Salvatore ButeraVolitionrx
73
Billy WhiteProPhase Labs
63
Terig HughesVolitionrx
54
Marcel KonradCaredx Inc
48
Gary PestanoBiodesix
57
Patricia CPAEnzo Biochem
47
Paul BeresfordBiodesix
N/A
Brett GiffinT2 Biosystms
65
Jonathan MEngNatera Inc
51
Bradley RadoffEnzo Biochem
47
Carissa RollinsIllumina
54
Jorge GarcesEXACT Sciences
52
SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. SQI Diagnostics Inc. was founded in 1999 and is headquartered in Toronto, Canada. Sqi Diagnostics is traded on OTC Exchange in the United States. SQI Diagnostics [SQIDF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

SQI Diagnostics Leadership Team

Elected by the shareholders, the SQI Diagnostics' board of directors comprises two types of representatives: SQI Diagnostics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SQI. The board's role is to monitor SQI Diagnostics' management team and ensure that shareholders' interests are well served. SQI Diagnostics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SQI Diagnostics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Andrew Morris, CEO and President and Director
Russell Peloquin, VP Operations
Eric Brouwer, Chief Scientific Officer
CFA CPA, CFO Admin
Peter Lea, Founder
Tim McGough, Chief Officer

SQI Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is SQI Diagnostics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Consideration for investing in SQI Pink Sheet

If you are still planning to invest in SQI Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SQI Diagnostics' history and understand the potential risks before investing.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments